1027382-45-1

Upstream product

• 1016-78-0 3-chlorobenzophenone 
• 123-25-1 succinic acid diethyl ester 

Downstream Products

• 152607-64-2 N-tert-butyl 2-(3-bromo-2-oxo-5-(3-chlorophenyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)ethanoic acid amide 
• 152607-72-2 N-tert-butyl 2-(3-bromo-2-oxo-5-phenyl-7-chloro-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)ethanoic acid amide 
• 152607-71-1 3-bromo-5-phenyl-7-chloro-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one 
• 152607-63-1 3-bromo-5-(3-chlorophenyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one 
• 152607-62-0 5-(3-chlorophenyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one 
• 1025806-11-4 4-(3-Chloro-phenyl)-4-phenyl-butyryl chloride 
• 152607-59-5 4-phenyl-4-(3-chlorophenyl)butanoic acid 
• 82101-37-9 4-(3-chlorophenyl)-1,2,3,4-tetrahydronaphth-1-one 
• 33898-20-3 5-phenyl-7-chloro-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one 

Relevant academic research and scientific papers

5-Phenyl-3-ureidobenzazepin-2-ones as cholecystokinin-B receptor antagonists

A series of 5-phenyl-3-ureidobenzazepin-2-one cholecystokinin-B (CCK-B) receptor antagonists was synthesized using Beckmann ring expansion of a suitable 4-phenyl-1-tetralone as a key step. Structure-activity relationship studies revealed the importance of